Yahoo
NYSE - Nasdaq Real Time Price USD

Stryker Corporation (SYK)

311.11 +7.11 (+2.34%)
As of 2:34:48 PM EDT. Market Open.
Trade Stryker on Coinbase
SYK Q3 2026 earnings call
Today at 4:30 PM EDT
Chart Range Bar
Loading chart for SYK

What's happening with SYK?

18m ago
Powered by Yahoo Scout

Stryker approaches its October 29, 2026, third-quarter earnings reportwith recovery efforts underway after cybersecurity and supply-chain disruptions. The company also completed its ZuriMED acquisition, expanding its shoulder-repair portfolio, while investors remain focused on margins, vascular backorders, and 2026 growth guidance.

Powered by Yahoo Scout
  • Previous Close 304.00
  • Open 306.99
  • Bid 311.16 x 16000
  • Ask 311.21 x 4000
  • Day's Range 305.87 - 312.80
  • 52 Week Range 267.00 - 389.33
  • Volume 1,627,966
  • Avg. Volume 2,651,900
  • Market Cap (intraday) 119.333B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 32.25
  • EPS (TTM) 9.65
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 3.52 (1.16%)
  • 1y Target Est 362.62
  • Morningstar Rating Rating available with Stock Picks access

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

www.stryker.com

56,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SYK
10.69%
S&P 500 (^GSPC)
12.38%

1-Year Return

SYK
14.86%
S&P 500 (^GSPC)
11.64%

3-Year Return

SYK
22.40%
S&P 500 (^GSPC)
86.84%

5-Year Return

SYK
23.31%
S&P 500 (^GSPC)
67.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 6.59B
Earnings 1.28B
Profit Margin 19.37%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
2B
4B
6B
12.0%
14.0%
16.0%
18.0%

Analyst Insights

View More

Analyst Price Targets

298.00
362.62 Average
311.11 Current
465.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/12/2026
Analyst BTIG
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 358 -> 316

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.43%

  • Return on Assets (ttm)

    8.16%

  • Return on Equity (ttm)

    16.51%

  • Revenue (ttm)

    25.84B

  • Net Income Avi to Common (ttm)

    3.73B

  • Diluted EPS (ttm)

    9.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.48B

  • Total Debt/Equity (mrq)

    64.39%

  • Levered Free Cash Flow (ttm)

    4.11B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: